e-Therapeutics plc (ETX) - Financial and Strategic SWOT Analysis Review

GlobalData, September 2012, Pages: 37

e-Therapeutics plc (ETX) - Financial and Strategic SWOT Analysis Review

Summary

e-Therapeutics plc (e-Therapeutics) is a pharmaceutical company, that conducts discovery and development of various drugs based on its proprietary network analysis technology. The company applies its novel, systematic approach to three areas of activity, namely, discovery of new drugs, discovering novel uses for existing drugs and analysis of the interactions between different drugs. The company provides drugs in the areas of cancer, asthma, anti-infectives and central nervous system. The products in the pipeline of e-Therapeutics include ETX1153a, ETX1153c and ETS6103. The company uses its novel, systematic approach in the discovery of new de-risked drugs, novel uses for existing drugs, and analysis of the interactions between different drugs. e-Therapeutics is headquartered in Newcastle upon Tyne, the UK.

The company focuses on discovering drug using its proprietary network analysis technology and license them to pharmaceutical company for late stage development and commercialization.

e-Therapeutics plc Key Recent Developments

May 22, 2012: e-Therapeutics Reports Fiscal 2012 Results
Feb 26, 2012: e-Therapeutics Opens New Drug Discovery Center Near Oxford
Jan 09, 2012: E-Therapeutics Outlines Goals For 2012 And Announces Presentation At Biotech Showcase Conference
Oct 19, 2011: e-Therapeutics Reports H1 Fiscal 2012 Results
Sep 26, 2011: e-Therapeutics Receives US Patent For Key Process In Drug Discovery Platform

This comprehensive SWOT profile of e-Therapeutics plc provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
e-Therapeutics plc - Key Facts
e-Therapeutics plc - Key Employees
e-Therapeutics plc - Key Employee Biographies
e-Therapeutics plc - Major Products and Services
e-Therapeutics plc - Pharmaceutical Pipeline Products Data
e-Therapeutics plc, Pipeline Products by Therapy Area
e-Therapeutics plc, Pipeline Products by Development Phase
e-Therapeutics plc - History
e-Therapeutics plc - Company Statement
e-Therapeutics plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
e-Therapeutics plc - Business Description
e-Therapeutics plc - SWOT Analysis
SWOT Analysis - Overview
e-Therapeutics plc - Strengths
Strength - Strong Technology Base
Strength - Focused Research and Development
e-Therapeutics plc - Weaknesses
Weakness - Lack of Marketed Products
Weakness - Weak Profitability Position
e-Therapeutics plc - Opportunities
Opportunity - Rising Healthcare Expenditure
Opportunity - Asthma-Market Potential
Opportunity - Growing Oncology Market
e-Therapeutics plc - Threats
Threat - Regulatory Environment
Threat - Uncertain R&D Outcomes
Threat - Cost Containment Pressures
e-Therapeutics plc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
e-Therapeutics plc, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
e-Therapeutics plc, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
e-Therapeutics plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
e-Therapeutics plc, Recent Developments
May 22, 2012: e-Therapeutics Reports Fiscal 2012 Results
Feb 26, 2012: e-Therapeutics Opens New Drug Discovery Center Near Oxford
Jan 09, 2012: E-Therapeutics Outlines Goals For 2012 And Announces Presentation At Biotech Showcase Conference
Oct 19, 2011: e-Therapeutics Reports H1 Fiscal 2012 Results
Sep 26, 2011: e-Therapeutics Receives US Patent For Key Process In Drug Discovery Platform
Jul 25, 2011: e-Therapeutics Reports Fiscal 2011 Results
Jun 13, 2011: e-Therapeutics Appoints Daniel Elger As CFO
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
e-Therapeutics plc, Key Facts
e-Therapeutics plc, Key Employees
e-Therapeutics plc, Key Employee Biographies
e-Therapeutics plc, Major Products and Services
e-Therapeutics plc, Number of Pipeline Products by Therapy Area
e-Therapeutics plc, Number of Pipeline Products by Development Stage
e-Therapeutics plc, Pipeline Products By Therapy Area and Development Phase
e-Therapeutics plc, History
e-Therapeutics plc, Subsidiaries
e-Therapeutics plc, Key Competitors
e-Therapeutics plc, Ratios based on current share price
e-Therapeutics plc, Annual Ratios
e-Therapeutics plc, Interim Ratios
e-Therapeutics plc, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
e-Therapeutics plc, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
e-Therapeutics plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
e-Therapeutics plc, Pipeline Products by Therapy Area
e-Therapeutics plc, Pipeline Products by Development Phase
e-Therapeutics plc, Performance Chart (2008 - 2012)
e-Therapeutics plc, Ratio Charts
e-Therapeutics plc, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
e-Therapeutics plc, Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012

SmartSensor telemed Ltd
Simbec Research Ltd
Scottish Biomedical
Alba Bioscience Limited
AMS Biotechnology (Europe) Ltd

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• eBay - Strong Execution
• Amazon - Point of Realization in 2013?
• Scientific Games Corporation - Company Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Ixia - Company Analysis
• SunGard - Profile - US
• Insight into Samsung Electronics' Notebook PC Business Model
• US - Accenture - Company Profile